If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


February 8, 2021 Cover

Volume 99, Issue 5

Researchers are repurposing nature's protein factories to accept a wider variety of substrates, with the goal of making new drugs and materials

Full Article
  • BASF says it is embracing the circular economy. Should we be skeptical?

    While critics see virtue signaling, the company heralds the adoption of a green economic opportunity

  • Clandestine chemistry and psychoactive drugs in film: Hamilton Morris talks about his career

    The journalist and scientist discusses his work documenting clandestine chemistry and the societal impact of psychoactive drugs

  • Love and the lab

    Columnist Jen Heemstra on how a supportive life partner shaped her career

image name

AstraZeneca, Gamaleya, Novavax, and J&J post positive vaccine results

Preliminary results from advanced studies of the COVID-19 vaccines are met with excitement—and trepidation about emerging virus variants